Stakeholders around the world can benefit from RWD as it can improve patient outcomes and speed at which products come to market.
Chitra Lele, PhD
Advertisement
Dr. Chitra Lele is Chief Scientific Officer, Sciformix Corporation.
Articles by Chitra Lele, PhD
The need for proactive pharmacovigilance is being increasingly acknowledged by all companies, regardless of their size and product mix, writes Dr. Chitra Lele.
Advertisement
Latest Updated Articles
The Power of Proactive PharmacovigilancePublished: April 21st 2015 | Updated: November 15th 2020
The Growing Importance of Real World DataPublished: February 18th 2017 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5